Biologic Infection Risk Factors — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Concurrent glucocorticoid exposure and previous serious infection
The best answer is “Concurrent glucocorticoid exposure and previous serious infection”. Serious-infection risk during biological therapy rises with glucocorticoid exposure, previous infection, older age, comorbidity and high disease activity. A young healthy patient with controlled disease has lower baseline risk, while serostatus, prior hydroxychloroquine alone and a remote mechanical injury are not comparable predictors.
Reference: BSR biologic DMARD safety guideline: https://academic.oup.com/rheumatology/article/58/2/e3/5076446